Výsledky vyhledávání - "A J, Vendrik"

Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery

Autor: C. P. J. Vendrik, Richard Sylvester, Allan T. van Oosterom, Stan B. Kaye, Gerrit Stoter, J. Keizer, W. G. Jones, Rob L.H. Jansen, Dirk T. Sleyfer, Sybren Meyer, Marleen de Pauw, Wim W. ten Bokkel Huinink

Publikováno v: European journal of cancer

From 1979 to 1983 the EORTC GU Group treated 239 patients with disseminated non-seminomatous testicular cancer with combination chemotherapy comprising cisplatin, vinblastine and bleomycin in a prospectively controlled trial. The protocol required co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b0eadf9dd9f7cd8b50c4cfaaa133361
https://doi.org/10.1016/0277-5379(91)90168-d

Zobrazit plný text záznamu

Response of sensitive and resistant IgM immunocytomas to cis-diamminedichloroplatinum (II) does not correlate with the platination level or with the formation or removal of DNA adducts

Autor: P. A. Steerenberg, A.M.J. Fichtinger-Schepman, Cornelis P. J. Vendrik, Gerard de Groot, W. H. de Jong, Wilhelmina C. M. van Dijk-Knijnenburg, Geert Frits Berends, Anke C. E. van der Minnen

Publikováno v: Cancer chemotherapy and pharmacology. 39(6)

An IgM immunocytoma cell line sensitive to cis-diamminedichloroplatinum(II) (CDDP) and a subline with acquired resistance were grown in LOU/M rats. In a previous study with such rats that had been treated with a high dose of CDDP (10 mg/kg) the tumor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f6bcf76a57f078ca448dcd5e3e8a29
https://pubmed.ncbi.nlm.nih.gov/9118458

Zobrazit plný text záznamu

Surveillance of stage 1 non-seminomatous testicular cancer: a preliminary report of the EORTC GU-Cooperative Group Surveillance Study

Autor: C. P. J. Vendrik, Jan H. Schornagel, F. Ten Kate, Richard Sylvester, J. Keizer, A.T. van Oosterom, K. Vermeylen, Jean-Pierre Droz, Ted A.W. Splinter, J. J. Croles

Publikováno v: Germ cell tumours: 3 / Jones, W.W. [edit.]

Publisher Summary This chapter presents a preliminary report of the EORTC GU-Cooperative Group Surveillance Study. The EORTC Genito-Urinary Cooperative Group decided to start a wait-and-see policy study to see if the data from the other centers could

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea94f3d52b9663ba560c8afc36926267
https://hdl.handle.net/10067/99090151162165141

Zobrazit plný text záznamu

Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

Autor: K. J. Roozendaal, G. Giaccone, Anne Kirkpatrick, M.G.J. Koolen, Pieter E. Postmus, W Bakker, J. Burghouts, Otilia Dalesio, C. P. J. Vendrik, G. McVie

Publikováno v: Journal of clinical oncology, 11(7), 1230-1240. American Society of Clinical Oncology

PURPOSE The present study investigates the role of short chemotherapy (five cycles) versus prolonged (12 cycles) chemotherapy in small-cell lung cancer (SCLC). PATIENTS AND METHODS Six hundred eighty-seven patients with SCLC were registered in a mult

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a133b78d542cc4ad55e4b1d61168bb
https://pubmed.ncbi.nlm.nih.gov/8391065

Zobrazit plný text záznamu

Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell Lung Cancer in a randomised phase II study

Autor: Anne Kirkpatrick, J.L. van de Lichte, F.M.L.H.G. Palmen, K. J. Roozendaal, G. Miech, G. Giaccone, J. Festen, Ted A.W. Splinter, Desmond N. Carney, D. Evrard, N. van Zandwijk, A.S.T. Planting, Elisabeth Quoix, Otilia Dalesio, M. Rinaldi, M. G. J. Koolen, J.Th.W. Burghouts, C. P. J. Vendrik, Pe Postmus

Publikováno v: European Journal of Cancer, 28(1), 96-100. ELSEVIER SCI LTD

The EORTC Lung Cancer Cooperative group performed a randomised phase II study in patients with small cell lung cancer comparing the standard cyclophosphamide/doxorubicin/etoposide (CDE) regimen with two regimens containing the new and active cisplati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dca737abe5832d0194e755716bfe443
https://research.rug.nl/en/publications/aa44382d-5d3f-4c6d-9b4a-754bd22bdca9

Zobrazit plný text záznamu

Multicenter phase II study of spiroplatin

Autor: H.M. Pinedo, K. J. Vendrik, T. A. W. Splinter, A. van Oosterom, M. E. L. Van Der Burg, W.W. ten Bokkel Huinink, D. T. H. Sleijfer, B. C. Tanis, E. van der Putten, Jan B. Vermorken

Publikováno v: Oncology

Spiroplatin was investigated in a multicenter phase II study, during which the drug was given over 4 h. 64 Patients with nine different solid tumors received 141 cycles of spiroplatin at a dose of 30 mg/m2 every 3 weeks. Most important side effects i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a0bbbd0bb07866e10d86858b375839c
https://pubmed.ncbi.nlm.nih.gov/1574259

Zobrazit plný text záznamu

A phase 1 and pharmacokinetic study using the aromatic retinoic acid analogue dichloroetretinate (Ro 12-7554)

Autor: C. P. J. Vendrik, J. H. Schornagel, A. v. Dijk, A. Struyvenberg, B. A. Zonnenberg

Publikováno v: Cancer chemotherapy and pharmacology. 25(4)

A phase I study was carried out with the new aromatic retinoic acid analogue DCE, all-trans-9-(2,6-dichloro-4-methoxy-m-tolyl)-3,7-dimethyl-2,4,6,8- nonatetraenacetylester. Data from preclinical studies show that DCE has a promising anti-tumor effect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1112e3300ad126a0376e8908acc885ce
https://pubmed.ncbi.nlm.nih.gov/2295113

Zobrazit plný text záznamu

Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin

Autor: H. Schraffordt Koops, D.Th. Sleyfer, R. Vriesendorp, W.W. ten Bokkel Huinink, H.M. Pinedo, C. P. J. Vendrik, A. Struyvenberg, Gerrit Stoter, A. van Oosterom

Publikováno v: Cancer. 54:1521-1524

Ninety-one patients with disseminated testicular non-seminomas were treated with 3 to 4 cycles of cisplatin, vinblastine, and bleomycin (PVB) induction chemotherapy followed by cisplatin and vinblastine maintenance therapy for 1 year. The follow-up o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b0caf07a762ebe59b2be0e3ef5cdd2cf
https://doi.org/10.1002/1097-0142(19841015)54:8<1521::aid-cncr2820540808>3.0.co

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání